Drug Interactions, Cardiac Toxicity, and Terfenadine

This publication has 14 references indexed in Scilit:

• The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered
  JAMA, 1993
• Fluvoxamine is a potent inhibitor of cytochrome P4501A2
  Biochemical Pharmacology, 1993
• Mechanism of the cardiotoxic actions of terfenadine
  JAMA, 1993
• Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin
  Clinical Pharmacology & Therapeutics, 1992
• The role of cytochrome P4502D6 in the metabolism of paroxetine by human liver microsomes.
  British Journal of Clinical Pharmacology, 1992
• Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics
  Biochemical Journal, 1992
• Toxic Interaction Between Fluvoxamine and Sustained Release Theophylline in an 11-Year-Old Boy
  Drug Safety, 1991
• Torsades de pointes occurring in association with terfenadine use
  JAMA, 1990
• Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man.
  Journal of Clinical Investigation, 1987
• Identification of an inducible form of cytochrome P-450 in human liver.
  Proceedings of the National Academy of Sciences, 1985